TCRT Kevin S. Boyle Sr. sold Alaunos Therapeutics, Inc. shares — SEC Form 4SELLAlaunos Therapeutics, Inc.

Kevin S. Boyle Sr., Chief Executive Officer at Alaunos Therapeutics, Inc. (TCRT), sold 68,014 shares at $0.14 ($10K) on 2023-09-01, disclosed to the SEC on 2023-09-05.

SEC EDGAR Filing

0000950170-23-046504

View on SEC EDGAR

Trade context

Scheduled sale ($10k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Modest52/100

Nothing distinguishes this filing.

Opportunistic Sell

Filing Info

Filed2023-09-05

Traded2023-09-01

Accession0000950170-23-046504

Sourcesec_form345

Insider

NameKevin S. Boyle Sr.

TitleChief Executive Officer

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
ZIOP	BUY	2021-11-17	$14K	—	Filing →

Get an email when an insider at TCRT files

Free account. Follow TCRT and up to 10 more companies.

Follow TCRT for free

TCRT Kevin S. Boyle Sr. sold Alaunos Therapeutics, Inc. shares — SEC Form 4SELLAlaunos Therapeutics, Inc.

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes